[ad_1]
PEOPLE at risk of Alzheimer’s will have access to a new-generation drug to stop the disease developing in the first place as part of a new trial. The Generation Study is recruiting thousands of people at risk of the condition for preventative treatment in the UK, Europe, US and Canada.
[ad_2]
Read More